Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Neonatal Therapeutics: Considerations for Dosing.

Zimmerman KO, Benjamin DK, Becker ML.

Am J Perinatol. 2019 Jul;36(S 02):S18-S21. doi: 10.1055/s-0039-1691772. Epub 2019 Jun 25.

PMID:
31238353
2.

Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants.

Gerhart JG, Watt KM, Edginton A, Wade KC, Salerno SN, Benjamin DK Jr, Smith PB, Hornik CP, Cohen-Wolkowiez M, Duara S, Ross A, Shattuck K, Stewart DL, Neu N, Gonzalez D; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee.

CPT Pharmacometrics Syst Pharmacol. 2019 May 14. doi: 10.1002/psp4.12414. [Epub ahead of print]

3.

A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network.

Bernard GR, Harris PA, Pulley JM, Benjamin DK, Michael J, Ford DE, Hanley DF, Selker HP, Wilkins CH.

J Clin Transl Sci. 2018 Aug;2(4):187-192. doi: 10.1017/cts.2018.319. Epub 2018 Nov 27.

PMID:
31011433
4.

Cefazolin pharmacokinetics in premature infants.

Balevic SJ, Smith PB, Testoni D, Wu H, Brouwer KLR, Zimmerman KO, Rivera-Chaparro ND, Benjamin DK Jr, Cohen-Wolkowiez M.

J Perinatol. 2019 Apr 3. doi: 10.1038/s41372-019-0368-z. [Epub ahead of print]

PMID:
30944398
5.

Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.

Smith PB, Cotten CM, Hudak ML, Sullivan JE, Poindexter BB, Cohen-Wolkowiez M, Boakye-Agyeman F, Lewandowski A, Anand R, Benjamin DK Jr, Laughon MM; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00284-19. doi: 10.1128/AAC.00284-19. Print 2019 Jun.

PMID:
30910891
6.

Impact of Gastrostomy Tube Placement on Short-Term Weight Gain in Hospitalized Premature Infants.

Puia-Dumitrescu M, Benjamin DK Sr, Smith PB, Greenberg RG, Abuzaid N, Andrews W, Chellani K, Gupta A, Price D, Williams C, Malcolm WF, Clark RH, Zimmerman KO.

JPEN J Parenter Enteral Nutr. 2019 Mar 25. doi: 10.1002/jpen.1539. [Epub ahead of print]

PMID:
30908714
7.

Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Watt KM, Hornik CP, Balevic SJ, Mundakel G, Cotten CM, Harper B, Benjamin DK Jr, Anand R, Laughon M, Smith PB, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee.

Br J Clin Pharmacol. 2019 May;85(5):1021-1027. doi: 10.1111/bcp.13882. Epub 2019 Mar 6.

PMID:
30710387
8.

Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.

Greenberg RG, Gayam S, Savage D, Tong A, Gorham D, Sholomon A, Clark RH, Benjamin DK, Laughon M, Smith PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

J Pediatr. 2019 May;208:134-140.e2. doi: 10.1016/j.jpeds.2018.11.043. Epub 2018 Dec 20.

PMID:
30579586
9.

Development of Therapeutics for Children-A Tricky Balancing Act.

Cohen-Wolkowiez M, Benjamin DK Jr.

JAMA Pediatr. 2019 Jan 1;173(1):18-19. doi: 10.1001/jamapediatrics.2018.4026. No abstract available.

PMID:
30452501
10.

Funding Pediatric Subspecialty Training: Are T32 Grants the Future?

Steinbach WJ, Benjamin DK Jr, Sleasman JW.

J Pediatr. 2018 Nov;202:4-7.e1. doi: 10.1016/j.jpeds.2018.08.035. No abstract available.

PMID:
30360878
11.

Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.

Autmizguine J, Smith PB, Prather K, Bendel C, Natarajan G, Bidegain M, Kaufman DA, Burchfield DJ, Ross AS, Pandit P, Schell WA, Gao J, Benjamin DK Jr; Fluconazole Prophylaxis Study Team .

J Antimicrob Chemother. 2018 Dec 1;73(12):3482-3487. doi: 10.1093/jac/dky353.

PMID:
30247579
12.

Evaluation of Gentamicin Exposure in the Neonatal Intensive Care Unit and Hearing Function at Discharge.

Puia-Dumitrescu M, Bretzius OM, Brown N, Fitz-Henley JA, Ssengonzi R, Wechsler CS, Gray KD, Benjamin DK Sr, Smith PB, Clark RH, Gonzalez D, Hornik CP.

J Pediatr. 2018 Dec;203:131-136. doi: 10.1016/j.jpeds.2018.07.101. Epub 2018 Sep 21.

13.

Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.

Tolia VN, Murthy K, Bennett MM, Greenberg RG, Benjamin DK, Smith PB, Clark RH.

J Pediatr. 2018 Dec;203:185-189. doi: 10.1016/j.jpeds.2018.07.061. Epub 2018 Sep 14.

PMID:
30220442
14.

Prevalence and safety of diazoxide in the neonatal intensive care unit.

Gray KD, Dudash K, Escobar C, Freel C, Harrison T, McMillan C, Puia-Dumitrescu M, Cotten CM, Benjamin R, Clark RH, Benjamin DK Jr, Greenberg RG; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee.

J Perinatol. 2018 Nov;38(11):1496-1502. doi: 10.1038/s41372-018-0218-4. Epub 2018 Sep 11.

15.

Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.

Wang LA, Smith PB, Laughon M, Goldberg RN, Ku LC, Zimmerman KO, Balevic S, Clark RH, Benjamin DK, Greenberg RG; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Early Hum Dev. 2018 Oct;125:26-30. doi: 10.1016/j.earlhumdev.2018.08.009. Epub 2018 Sep 4.

PMID:
30193125
16.

Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants.

Kumar KR, Clark DA, Kim EM, Perry JD, Wright K, Thomas SA, Thompson EJ, Greenberg RG, Smith PB, Benjamin DK Jr, Laughon MM, Clark RH, Hornik CP.

J Pediatr. 2018 Nov;202:56-62.e2. doi: 10.1016/j.jpeds.2018.07.024. Epub 2018 Aug 29.

17.

Predictors of Prolonged Breast Milk Provision to Very Low Birth Weight Infants.

Romaine A, Clark RH, Davis BR, Hendershot K, Kite V, Laughon M, Updike I, Miranda ML, Meier PP, Patel AL, Smith PB, Cotten CM, Benjamin DK Jr, Greenberg RG.

J Pediatr. 2018 Nov;202:23-30.e1. doi: 10.1016/j.jpeds.2018.07.001. Epub 2018 Aug 28.

PMID:
30170862
18.

Pediatric Antibacterial and Antifungal Trials From 2007 to 2017.

Thaden JT, Chiswell K, Jaffe I, Bergin SP, Yang WE, Romaine A, Roberts J, Nambiar S, Farley J, Benjamin DK Jr, Smith PB, Tsalik EL.

Pediatrics. 2018 Sep;142(3). pii: e20171849. doi: 10.1542/peds.2017-1849.

PMID:
30158197
19.

A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents.

Shakhnovich V, Brian Smith P, Guptill JT, James LP, Collier DN, Wu H, Livingston CE, Zhao J, Kearns GL, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act–Pediatric Trials Network.

Paediatr Drugs. 2018 Oct;20(5):483-495. doi: 10.1007/s40272-018-0305-1.

PMID:
30097906
20.

Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.

Gonzalez D, James LP, Al-Uzri A, Bosheva M, Adler-Shohet FC, Mendley SR, Bradley JS, Espinosa C, Tsonkova E, Moffett K, Marquez L, Simonsen KA, Stoilov S, Boakye-Agyeman F, Jasion T, Hornik CP, Hernandez R, Benjamin DK Jr, Cohen-Wolkowiez M.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00692-18. doi: 10.1128/AAC.00692-18. Print 2018 Aug.

21.

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.

Kovanda LL, Walsh TJ, Benjamin DK Jr, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW.

Pediatr Infect Dis J. 2018 Jun;37(6):580-585. doi: 10.1097/INF.0000000000001957.

22.

Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators.

Corneli A, Wheeler C, Bradley J, Gamel B, Nambiar S, Noel GJ, Lin L, Roberts JN, Benjamin DK Jr.

Contemp Clin Trials Commun. 2018 Jan 31;9:115-120. doi: 10.1016/j.conctc.2018.01.003. eCollection 2018 Mar.

23.

Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.

Greenberg RG, Gamel B, Bloom D, Bradley J, Jafri HS, Hinton D, Nambiar S, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr.

Contemp Clin Trials Commun. 2017 Nov 23;9:33-39. doi: 10.1016/j.conctc.2017.11.005. eCollection 2018 Mar.

24.

Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.

Greenberg RG, Corneli A, Bradley J, Farley J, Jafri HS, Lin L, Nambiar S, Noel GJ, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr.

Contemp Clin Trials Commun. 2017 Nov 26;9:7-12. doi: 10.1016/j.conctc.2017.11.006. eCollection 2018 Mar.

25.

Voriconazole Treatment for an Infant With Intractable Candida glabrata Meningitis.

Tsakiri S, Aneji C, Domonoske C, Mazur L, Benjamin DK Jr, Wootton SH.

Pediatr Infect Dis J. 2018 Oct;37(10):999-1001. doi: 10.1097/INF.0000000000002073.

PMID:
29677084
26.

Safety, Effectiveness and Exposure-response of Micafungin in Infants: Application of an Established Pharmacokinetics Model to Electronic Health Records.

Rivera-Chaparro ND, Ericson J, Wu H, Smith PB, Clark RH, Benjamin DK Jr, Cohen-Wolkowiez M, Greenberg RG.

Pediatr Infect Dis J. 2019 Feb;38(2):e26-e28. doi: 10.1097/INF.0000000000002045.

PMID:
29601453
27.

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.

Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ.

Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996. Erratum in: Pediatr Infect Dis J. 2018 Nov;37(11):1198.

28.

A directory for neonatal intensive care: potential for facilitating network-based research in neonatology.

Ariagno RL, Lee HC, Stevenson DK, Benjamin DK Jr, Smith PB, Escobedo MB, Bhatt DR.

J Perinatol. 2018 Aug;38(8):954-958. doi: 10.1038/s41372-018-0097-8. Epub 2018 Mar 15.

PMID:
29545621
29.

Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures.

Shakhnovich V, Smith PB, Guptill JT, James LP, Collier DN, Wu H, Livingston CE, Zhao J, Kearns GL; Best Pharmaceuticals for Children Act – Pediatric Trials Network.

J Pediatr. 2018 Feb;193:102-108.e1. doi: 10.1016/j.jpeds.2017.10.011.

30.

Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.

Autmizguine J, Tan S, Cohen-Wolkowiez M, Cotten CM, Wiederhold N, Goldberg RN, Adams-Chapman I, Stoll BJ, Smith PB, Benjamin DK Jr; NICHD Neonatal Research Network.

Pediatr Infect Dis J. 2018 Sep;37(9):923-929. doi: 10.1097/INF.0000000000001913.

PMID:
29369937
31.

Coordination of the Environmental influences on Child Health Outcomes program: so the whole is greater than the sum of its parts.

Smith B, Knox S, Benjamin DK Jr.

Curr Opin Pediatr. 2018 Apr;30(2):263-268. doi: 10.1097/MOP.0000000000000598. Review.

32.

Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.

Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Blackford M, Yogev R, James LP, Melloni C, Harper B, Mitchell J, Benjamin DK Jr, Boakye-Agyeman F, Cohen-Wolkowiez M.

Ther Drug Monit. 2018 Feb;40(1):103-108. doi: 10.1097/FTD.0000000000000466.

33.

Early lumbar puncture and risk of intraventricular hemorrhage in very low birth weight infants.

Testoni D, Hornik CP, Guinsburg R, Clark RH, Greenberg RG, Benjamin DK Jr, Smith PB.

Early Hum Dev. 2018 Feb;117:1-6. doi: 10.1016/j.earlhumdev.2017.11.013. Epub 2017 Dec 5.

PMID:
29220639
34.

Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.

Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH.

J Perinatol. 2018 Jan;38(1):75-79. doi: 10.1038/jp.2017.157. Epub 2017 Oct 19.

PMID:
29048415
35.

Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.

Watt KM, Cohen-Wolkowiez M, Williams DC, Bonadonna DK, Cheifetz IM, Thakker D, Benjamin DK Jr, Brouwer KLR.

J Extra Corpor Technol. 2017 Sep;49(3):150-159.

36.

The Need for Pediatric Drug Development.

Ward RM, Benjamin DK Jr, Davis JM, Gorman RL, Kauffman R, Kearns GL, Murphy MD, Sherwin CMT.

J Pediatr. 2018 Jan;192:13-21. doi: 10.1016/j.jpeds.2017.08.011. Epub 2017 Sep 21. No abstract available.

PMID:
28942898
37.

External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models.

Hwang MF, Beechinor RJ, Wade KC, Benjamin DK Jr, Smith PB, Hornik CP, Capparelli EV, Duara S, Kennedy KA, Cohen-Wolkowiez M, Gonzalez D.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01352-17. doi: 10.1128/AAC.01352-17. Print 2017 Dec.

38.

Early Caffeine Prophylaxis and Risk of Failure of Initial Continuous Positive Airway Pressure in Very Low Birth Weight Infants.

Patel RM, Zimmerman K, Carlton DP, Clark R, Benjamin DK, Smith PB.

J Pediatr. 2017 Nov;190:108-111.e1. doi: 10.1016/j.jpeds.2017.07.006. Epub 2017 Sep 7.

39.

Effect of renal function on antihypertensive drug safety and efficacy in children.

Watt KM, Avant D, Sherwin J, Benjamin DK, Hornik C, Benjamin DK Jr, Li JS, Smith PB.

Pediatr Nephrol. 2018 Jan;33(1):139-146. doi: 10.1007/s00467-017-3763-8. Epub 2017 Aug 4.

40.

Pharmacokinetics of Clindamycin in Obese and Nonobese Children.

Smith MJ, Gonzalez D, Goldman JL, Yogev R, Sullivan JE, Reed MD, Anand R, Martz K, Berezny K, Benjamin DK Jr, Smith PB, Cohen-Wolkowiez M, Watt K; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02014-16. doi: 10.1128/AAC.02014-16. Print 2017 Apr.

41.

Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone.

Virkud YV, Hornik CP, Benjamin DK, Laughon MM, Clark RH, Greenberg RG, Smith PB.

J Pediatr. 2017 Apr;183:26-30.e3. doi: 10.1016/j.jpeds.2016.12.035. Epub 2017 Jan 18.

42.

Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.

Ericson JE, Gostelow M, Autmizguine J, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB; Pediatric Trials Network Executive Committee and Investigators.

Pediatr Infect Dis J. 2017 Apr;36(4):369-373. doi: 10.1097/INF.0000000000001451.

43.

Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.

Gonzalez D, Chamberlain JM, Guptill JT, Cohen-Wolkowiez M, Harper B, Zhao J, Capparelli EV; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Clin Pharmacokinet. 2017 Aug;56(8):941-951. doi: 10.1007/s40262-016-0486-0.

44.

Timing of Multiorgan Dysfunction among Hospitalized Infants with Fatal Fulminant Sepsis.

Wynn JL, Kelly MS, Benjamin DK, Clark RH, Greenberg R, Benjamin DK Jr, Smith PB.

Am J Perinatol. 2017 Jun;34(7):633-639. doi: 10.1055/s-0036-1597130. Epub 2016 Dec 6.

45.

Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.

Parente V, Clark RH, Ku L, Fennell C, Johnson M, Morris E, Romaine A, Utin U, Benjamin DK, Messina JA, Smith PB, Greenberg RG.

J Perinatol. 2017 Feb;37(2):157-161. doi: 10.1038/jp.2016.201. Epub 2016 Nov 17.

46.

Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care Unit.

Ku LC, Zimmerman K, Benjamin DK, Clark RH, Hornik CP, Smith PB; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Pediatr Cardiol. 2017 Jan;38(1):155-161. doi: 10.1007/s00246-016-1496-2. Epub 2016 Nov 8.

47.

Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.

Hornik CP, Benjamin DK Jr, Smith PB, Pencina MJ, Tremoulet AH, Capparelli EV, Ericson JE, Clark RH, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act—Pediatric Trials Network.

J Pediatr. 2016 Nov;178:125-129.e1. doi: 10.1016/j.jpeds.2016.07.011. Epub 2016 Aug 10.

48.

Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.

Autmizguine J, Hornik CP, Benjamin DK Jr, Brouwer KL, Hupp SR, Cohen-Wolkowiez M, Watt KM.

Pediatr Infect Dis J. 2016 Nov;35(11):1204-1210.

49.

The Role of a Division of Quantitative Sciences Division in Enhancing Academic Productivity of a Department of Pediatrics.

Smith PB, Benjamin DK Jr, Reed AM.

J Pediatr. 2017 Jan;180:4-5. doi: 10.1016/j.jpeds.2016.09.042. Epub 2016 Oct 11. No abstract available.

50.

Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia.

Lee JA, Sauer B, Tuminski W, Cheong J, Fitz-Henley J 2nd, Mayers M, Ezuma-Igwe C, Arnold C, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB, Ericson JE; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Am J Perinatol. 2017 Apr;34(5):458-464. doi: 10.1055/s-0036-1593349. Epub 2016 Sep 20.

Supplemental Content

Loading ...
Support Center